Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.

Advisory groups

Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD)
In 2018, the World Health Organization (WHO) established the Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD) to act as an advisory body to matters of global policies and strategies related to in vitro diagnostics (IVDs).

Publications

All →

Blood transfusion is a vital component of modern health care and can be life-saving in many clinical situations. However, it is not without risks, including...

WHO guideline on balanced national controlled medicines policies to ensure medical access and safety: rapid communication

WHO recommends that essential medicines, including those that are controlled, be available to all patients at all times at a price that the individual...

Guidance on implementing patient blood management to improve global blood health status

Incorporating expertise from peers working in countries where health care faces extreme resource constraints, attention  is paid to how PBM processes...

WHO Drug Information - Volume 39, No. 1

The first issue of volume 39 for 2025 includes:Consultation Documents: - "Aminosalicylate sodium dihydrate (aminosalicylatum natricum dihydricus)"- "Aminosalicylate...